- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07749690
Mental Rotation and Motor Imagery Training in Multiple Sclerosis
August 5, 2026 updated by: Ramazan KURUL, Abant Izzet Baysal University
Mental Rotation and Motor Imagery Training for Upper-Extremity Function in Relapsing-Remitting Multiple Sclerosis: A Randomized Controlled Trial
This randomized controlled trial investigated the effects of sequential laterality, motor imagery, and mental rotation training in individuals with relapsing-remitting multiple sclerosis.
Both groups received conventional physiotherapy, while the intervention group received structured cognitive-motor training and the control group received active visual-attention training.
Study Overview
Status
Completed
Conditions
Detailed Description
Fifty-four participants were randomly assigned to the intervention or control group.
Both groups received 45-minute sessions three times per week for six weeks.
Mental rotation ability was the primary outcome, while upper-extremity function, manual ability, motor imagery, grip strength, dexterity, and information-processing speed were assessed as secondary outcomes.
Assessments were performed before and after the intervention by a researcher blinded to group allocation.
Study Type
Interventional
Enrollment (Actual)
54
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bolu, Turkey (Türkiye), 14100
- Abant Izzet Baysal University Faculty of Health Science
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosed with definite relapsing-remitting multiple sclerosis by a neurologist according to the revised McDonald criteria
- Not experiencing an acute MS relapse
- Mini Mental State Examination score ≥24
- No clinical MS relapse within the previous 3 months
- No corticosteroid treatment for an MS relapse within the previous 3 months
- Expanded Disability Status Scale score between 1.5 and 6.0
- Modified Ashworth Scale score ≤2
- Sufficient communication ability to understand visual and verbal instructions and follow the training protocol
- Able to attend at least 80% of the planned sessions
- Able to complete the Movement Imagery Questionnaire-3
Exclusion Criteria:
- Any medication change within the previous 3 months
- Uncorrected severe visual or hearing impairment
- A communication disorder preventing the perception of or response to the visual and verbal stimuli used in the study
- Participation in another structured upper-extremity rehabilitation program or interventional study during the study period
- Presence of an additional neurological disorder
- Advanced sensory loss or proprioceptive impairment that could affect participation in the intervention
- Botulinum toxin injection within the previous 3 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Multicomponent rotation training
Participants received 30 minutes of conventional physiotherapy and 15 minutes of sequential laterality, motor imagery, and mental rotation training, three times per week for six weeks.
|
Participants received 30 minutes of conventional physiotherapy followed by 15 minutes of structured training, three times per week for six weeks.
The training progressed sequentially through laterality recognition, motor imagery, and mental rotation.
Laterality training involved identifying right- and left-hand images.
Motor imagery training involved imagining the hand positions and movements shown in the images without performing an observable movement.
Mental rotation training involved mentally rotating figures and selecting the correct response.
|
|
Sham Comparator: Sham training
Participants received 30 minutes of conventional physiotherapy and 15 minutes of active visual-attention training using neutral objects, colors, shapes, and symbols, three times per week for six weeks.
|
Participants received 30 minutes of conventional physiotherapy followed by 15 minutes of active visual-attention control training, three times per week for six weeks.
The training included images of neutral objects, colors, geometric shapes, and symbols that did not depict body parts.
Participants classified the images according to color, shape, size, position, or similarity and difference.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Purdue Spatial Visualization Test
Time Frame: Baseline and immediately after the 6-week intervention.
|
The Purdue Spatial Visualization Test a widely used mental rotation tests, consists of 30 three-dimensional spatial perception questions.
|
Baseline and immediately after the 6-week intervention.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Symbol Digit Modalities Test
Time Frame: Baseline and immediately after the 6-week intervention.
|
The Symbol Digit Modalities Test is a widely used assessment tool for measuring information-processing speed in patients with MS.
|
Baseline and immediately after the 6-week intervention.
|
|
Nine-Hole Peg Test
Time Frame: Baseline and immediately after the 6-week intervention.
|
In the Nine-Hole Peg Test, nine wooden pegs were placed into a wooden board containing nine holes using one hand.
|
Baseline and immediately after the 6-week intervention.
|
|
Kinesthetic and Visual Imagery Questionnaire
Time Frame: Baseline and immediately after the 6-week intervention.
|
Motor imagery ability was evaluated and scored using 20 items examining movements of different body parts in a sitting position, with two subscales assessing kinesthetic and visual imagery abilities.
The total score ranges from 10 to 50, with each subscale ranging from 5 to 25.
|
Baseline and immediately after the 6-week intervention.
|
|
Grip Strength
Time Frame: Baseline and immediately after the 6-week intervention
|
Grip strength was assessed using a Jamar hand dynamometer.
|
Baseline and immediately after the 6-week intervention
|
|
Abilhand
Time Frame: Baseline and immediately after the 6-week intervention.
|
Abilhand is a patient-reported scale used to determine the perceived level of difficulty individuals experience when using their hands during activities of daily living.
The Abilhand total raw score ranges from 0 to 46, with higher scores indicating better self-perceived manual ability in performing daily bimanual activities.
|
Baseline and immediately after the 6-week intervention.
|
|
The Action Research Arm Test (ARAT)
Time Frame: Baseline and immediately after the 6-week intervention.
|
The Action Research Arm Test was used to evaluate upper extremity functional capacity and consists of four subdomains: grasp, grip, pinch, and gross movement.
|
Baseline and immediately after the 6-week intervention.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Enes Tayyip Benli, phd, Abant Izzet Baysal University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 15, 2024
Primary Completion (Actual)
January 15, 2026
Study Completion (Actual)
February 15, 2026
Study Registration Dates
First Submitted
July 30, 2026
First Submitted That Met QC Criteria
August 5, 2026
First Posted (Actual)
August 6, 2026
Study Record Updates
Last Update Posted (Actual)
August 6, 2026
Last Update Submitted That Met QC Criteria
August 5, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AIBU-FTR-BENLI-010
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.